Differential expression of extracellular matrix-related genes in rare variants of meningioma

Mi Jung Kwon1, Chang Ohk Sung, So Young Kang

  • 1Department of Pathology, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, Anyang, Gyeonggi-do 431-070, South Korea.

Human Pathology
|September 22, 2012
PubMed

Insights

Extracellular matrix proteins differ in rare meningioma subtypes. High matrix metalloproteinase 9 expression is linked to rhabdoid meningioma recurrence and poorer survival.

Area of Science:

  • Neuro-oncology
  • Molecular Pathology
  • Tumor Biology

Background:

  • Meningiomas are tumors arising from the meninges.
  • Secretory, clear cell, and rhabdoid meningiomas are rare subtypes with distinct characteristics.
  • The role of extracellular matrix (ECM) proteins in these rare meningioma variants is not well understood.

Purpose of the Study:

  • To investigate the expression patterns of specific ECM proteins in secretory, clear cell, and rhabdoid meningiomas.
  • To determine the clinicopathologic significance of these ECM proteins, particularly in relation to tumor behavior and patient outcomes.

Main Methods:

  • Analysis of 51 meningioma cases (12 secretory, 9 clear cell, 30 rhabdoid).
  • Evaluation of matrix metalloproteinase 2 (MMP-2), matrix metalloproteinase 9 (MMP-9), galectin-3, fibronectin, and collagen IV expression.
  • Correlation of gene expression (mRNA) with protein immunoexpression and clinicopathologic data.

Main Results:

  • Distinct ECM protein expression patterns were observed across the three meningioma subtypes.
  • Secretory meningiomas showed high fibronectin and galectin-3 expression.
  • Clear cell meningiomas exhibited high MMP-2, MMP-9, and collagen IV expression.
  • Rhabdoid meningiomas displayed high MMP-9, galectin-3, and fibronectin expression.
  • High MMP-9 expression correlated with tumor recurrence and local invasion.
  • In rhabdoid meningiomas, high MMP-9 was associated with shorter recurrence-free survival.

Conclusions:

  • Differential expression of ECM proteins is associated with specific meningioma histologic subtypes.
  • ECM protein expression, particularly MMP-9, plays a role in the biologic behavior and clinical outcomes of these rare meningiomas.
  • High MMP-9 expression is a significant indicator of recurrence risk in rhabdoid meningiomas.